| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.014 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |